1. Home
  2. TMDX vs RH Comparison

TMDX vs RH Comparison

Compare TMDX & RH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RH
  • Stock Information
  • Founded
  • TMDX 1998
  • RH 1979
  • Country
  • TMDX United States
  • RH United States
  • Employees
  • TMDX N/A
  • RH N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RH Other Specialty Stores
  • Sector
  • TMDX Health Care
  • RH Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • RH Nasdaq
  • Market Cap
  • TMDX 4.0B
  • RH 3.2B
  • IPO Year
  • TMDX 2019
  • RH 1998
  • Fundamental
  • Price
  • TMDX $115.50
  • RH $158.91
  • Analyst Decision
  • TMDX Buy
  • RH Buy
  • Analyst Count
  • TMDX 11
  • RH 16
  • Target Price
  • TMDX $130.73
  • RH $260.27
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • RH 858.9K
  • Earning Date
  • TMDX 10-29-2025
  • RH 12-11-2025
  • Dividend Yield
  • TMDX N/A
  • RH N/A
  • EPS Growth
  • TMDX 170.70
  • RH 207.98
  • EPS
  • TMDX 2.54
  • RH 5.35
  • Revenue
  • TMDX $566,354,000.00
  • RH $3,337,241,000.00
  • Revenue This Year
  • TMDX $38.84
  • RH $13.15
  • Revenue Next Year
  • TMDX $20.46
  • RH $10.14
  • P/E Ratio
  • TMDX $45.56
  • RH $29.57
  • Revenue Growth
  • TMDX 41.20
  • RH 9.56
  • 52 Week Low
  • TMDX $55.00
  • RH $123.03
  • 52 Week High
  • TMDX $145.50
  • RH $457.26
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 42.14
  • RH 36.05
  • Support Level
  • TMDX $115.21
  • RH $155.51
  • Resistance Level
  • TMDX $125.57
  • RH $167.60
  • Average True Range (ATR)
  • TMDX 7.47
  • RH 8.60
  • MACD
  • TMDX -1.51
  • RH -0.36
  • Stochastic Oscillator
  • TMDX 4.92
  • RH 6.74

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RH RH

RH is a luxury furniture and lifestyle retailer operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 23 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

Share on Social Networks: